| Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network L Chorro, A Sarde, M Li, KJ Woollard, P Chambon, B Malissen, ... Journal of Experimental Medicine 206 (13), 3089-3100, 2009 | 458 | 2009 |
| Immunoregulatory functions of VISTA EC Nowak, JL Lines, FS Varn, J Deng, A Sarde, R Mabaera, A Kuta, ... Immunological reviews 276 (1), 66-79, 2017 | 200 | 2017 |
| B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease T Satoh, A Smith, A Sarde, H Lu, S Mian, C Trouillet, G Mufti, JF Emile, ... PloS one 7 (4), e33891, 2012 | 182 | 2012 |
| Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program CC Brown, D Esterhazy, A Sarde, M London, V Pullabhatla, ... Immunity 42 (3), 499-511, 2015 | 164 | 2015 |
| Hypoxia-induced VISTA promotes the suppressive function of myeloid-derived suppressor cells in the tumor microenvironment J Deng, J Li, A Sarde, JL Lines, YC Lee, DC Qian, DA Pechenick, ... Cancer immunology research 7 (7), 1079-1090, 2019 | 150 | 2019 |
| Defining the signature of VISTA on myeloid cell chemokine responsiveness TWK Broughton, MA ElTanbouly, E Schaafsma, J Deng, A Sarde, ... Frontiers in immunology 10, 2641, 2019 | 42 | 2019 |
| Chronic rejection of cardiac allografts is associated with increased lymphatic flow and cellular trafficking LA Edwards, AK Nowocin, NV Jafari, LL Meader, K Brown, A Sarde, ... Circulation 137 (5), 488-503, 2018 | 38 | 2018 |
| VISTA targeting of T-cell quiescence and myeloid suppression overcomes adaptive resistance E Schaafsma, W Croteau, M ElTanbouly, EC Nowak, NC Smits, J Deng, ... Cancer immunology research 11 (1), 38-55, 2023 | 15 | 2023 |
| VISTA is a novel regulator of macrophage biology P Shah, M Eltanbouly, N Smits, A Sarde, R Noelle, R Mabaera Blood 134, 2320, 2019 | 3 | 2019 |
| Role of retinoic acid in the stability of the T-helper-type 1 lineage and implications for autoimmunity C Brown, D Esterhazy, A Sarde, V Pullabhatla, M London, M Arno, ... The Lancet 385, S25, 2015 | 3 | 2015 |
| VISTA is a checkpoint regulator for myeloid cells JL Lines, A Sarde, E Usherwood, R Noelle Immunology 143, 183-183, 2014 | 1 | 2014 |
| Vista blockade reprograms tumor myeloid cells and relieves adaptive resistance JL Lines, E Schaafsma, W Croteau, EC Nowak, M ElTanbouly, A Sarde, ... The Journal of Immunology 208 (1_Supplement), 176.04-176.04, 2022 | | 2022 |
| Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms (vol 31, pg 705, year 2017) T Satoh, A Smith, A Sarde HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 32 (2), XIII-XIII, 2018 | | 2018 |
| Quantification of lymphatic flow using SPECT/CT lymphoscintigraphy reveals increased lymph flow during chronic rejection LA Edwards, AK Nowocin, NV Jafari, LL Meader, K Brown, A Sarde, ... TRANSPLANTATION 100 (7), S359-S360, 2016 | | 2016 |
| Retinoic acid signalling constrains the plasticity of Th1 cells and prevents development of hybrid Th1-Th17 cells C Brown, A Sarde, G Lord, R Noelle IMMUNOLOGY 143, 74-74, 2014 | | 2014 |
